Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25303-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- TRIP12 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TRIP12 antibody (Cat. #25303-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Dynamic regulation of the oxidative stress response by the E3 ligase TRIP12.
NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance.
Combinatorial ubiquitin code degrades deubiquitylation-protected substrates.
Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis.
Dynamic regulation of the oxidative stress response by the E3 ligase TRIP12.
Intrinsic signaling pathways modulate targeted protein degradation.
EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma.
TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.
Ingersoll AJ, McCloud DM, Hu JY, Rape M
Cell reports 2025 Sep 23;44(9):116262
Cell reports 2025 Sep 23;44(9):116262
NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance.
Lin J, Yin Y, Cao J, Zhang Y, Chen J, Chen R, Zou B, Huang C, Lv Y, Xu S, Yang H, Lin P, Xie D
Cell discovery 2025 May 28;11(1):52
Cell discovery 2025 May 28;11(1):52
Combinatorial ubiquitin code degrades deubiquitylation-protected substrates.
Morita M, Takao M, Tokuhisa H, Chiba R, Tomomatsu S, Akizuki Y, Tomita T, Endo A, Saeki Y, Sato Y, Ohtake F
Nature communications 2025 Mar 24;16(1):2496
Nature communications 2025 Mar 24;16(1):2496
Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis.
Wang X, Guo T, Niu L, Zheng B, Huang W, Xu H, Huang W
Oncogene 2024 Sep;43(38):2850-2867
Oncogene 2024 Sep;43(38):2850-2867
Dynamic regulation of the oxidative stress response by the E3 ligase TRIP12.
Ingersoll AJ, McCloud DM, Hu JY, Rape M
bioRxiv : the preprint server for biology 2024 Nov 25;
bioRxiv : the preprint server for biology 2024 Nov 25;
Intrinsic signaling pathways modulate targeted protein degradation.
Mori Y, Akizuki Y, Honda R, Takao M, Tsuchimoto A, Hashimoto S, Iio H, Kato M, Kaiho-Soma A, Saeki Y, Hamazaki J, Murata S, Ushijima T, Hattori N, Ohtake F
Nature communications 2024 Jul 2;15(1):5379
Nature communications 2024 Jul 2;15(1):5379
EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma.
Li B, Zhou Q, Wan Q, Qiao X, Chen S, Zhou J, Wuxiao Z, Luo L, Ng SB, Li J, Chng WJ
Clinical epigenetics 2023 Nov 29;15(1):187
Clinical epigenetics 2023 Nov 29;15(1):187
TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.
Kaiho-Soma A, Akizuki Y, Igarashi K, Endo A, Shoda T, Kawase Y, Demizu Y, Naito M, Saeki Y, Tanaka K, Ohtake F
Molecular cell 2021 Apr 1;81(7):1411-1424.e7
Molecular cell 2021 Apr 1;81(7):1411-1424.e7
No comments: Submit comment
No validations: Submit validation data